| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/19/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 04/12/2022 | 1066.67% | Maxim Group | → $14 | Initiates Coverage On | → Buy |
What is the target price for Synaptogenix (SNPX)?
The latest price target for Synaptogenix (NASDAQ: SNPX) was reported by Maxim Group on December 19, 2022. The analyst firm set a price target for $0.00 expecting SNPX to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Synaptogenix (SNPX)?
The latest analyst rating for Synaptogenix (NASDAQ: SNPX) was provided by Maxim Group, and Synaptogenix downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Synaptogenix (SNPX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Synaptogenix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Synaptogenix was filed on December 19, 2022 so you should expect the next rating to be made available sometime around December 19, 2023.
Is the Analyst Rating Synaptogenix (SNPX) correct?
While ratings are subjective and will change, the latest Synaptogenix (SNPX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Synaptogenix (SNPX) is trading at is $1.20, which is out of the analyst's predicted range.